• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

苯巴比妥在儿科患者血清、脑及其他器官中的分布。

Distribution of phenobarbital in serum, brain and other organs from pediatric patients.

作者信息

Onishi S, Ohki Y, Nishimura Y, Itoh S, Isobe K, Hosoe A, Yamamoto T, Yamakawa T

出版信息

Dev Pharmacol Ther. 1984;7(3):153-9. doi: 10.1159/000457158.

DOI:10.1159/000457158
PMID:6723490
Abstract

The present study was performed to determine whether serum levels of phenobarbital were representative of their concentrations in the brains obtained from 11 autopsied patients, including premature and full-term babies, infants and children. Estimation of phenobarbital concentrations in plasma and organs was performed by high-pressure liquid chromatography. Brain phenobarbital concentrations correlated well with serum levels (r = 0.82, p less than 0.01, n = 11), giving a regression line with a slope of 0.75. It can be concluded that estimating the serum phenobarbital concentration during clinical pediatric practice gives a good indication of the brain concentration.

摘要

本研究旨在确定11例尸检患者(包括早产儿、足月儿、婴儿和儿童)血清中苯巴比妥水平是否代表其大脑中的浓度。采用高压液相色谱法测定血浆和器官中苯巴比妥的浓度。脑苯巴比妥浓度与血清水平相关性良好(r = 0.82,p < 0.01,n = 11),回归直线斜率为0.75。可以得出结论,在临床儿科实践中估算血清苯巴比妥浓度能很好地反映大脑中的浓度。

相似文献

1
Distribution of phenobarbital in serum, brain and other organs from pediatric patients.苯巴比妥在儿科患者血清、脑及其他器官中的分布。
Dev Pharmacol Ther. 1984;7(3):153-9. doi: 10.1159/000457158.
2
Phenobarbital disposition in the neonate.苯巴比妥在新生儿体内的处置
Addict Dis. 1975;2(1-2):179-85.
3
Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses.单次给药后婴儿体内苯巴比妥的血浆和脑脊液浓度
Dev Med Child Neurol. 1974 Dec;16(6):781-93.
4
[Phenobarbital in newborn infants. Overview].[新生儿中的苯巴比妥。概述]
Monatsschr Kinderheilkd. 1984 Apr;132(4):194-202.
5
Pharmacokinetics of phenobarbital in childhood.苯巴比妥在儿童期的药代动力学。
Eur J Clin Pharmacol. 1977 Dec 2;12(4):305-10. doi: 10.1007/BF00607431.
6
Plasma concentrations of phenobarbital in the treatment of seizures in newborns.苯巴比妥用于新生儿癫痫治疗时的血浆浓度
Acta Paediatr Scand. 1975 May;64(3):514-24. doi: 10.1111/j.1651-2227.1975.tb03873.x.
7
Efficacy of phenobarbital monotherapy in treatment of neonatal seizures -- relationship to blood levels.苯巴比妥单药治疗新生儿惊厥的疗效——与血药浓度的关系
Neurology. 1982 Dec;32(12):1401-4. doi: 10.1212/wnl.32.12.1401.
8
Safety of a higher loading dose of phenobarbital in the term newborn.
Pediatrics. 1985 Jun;75(6):1061-4.
9
Rapid sequential phenobarbital treatment of neonatal seizures.新生儿惊厥的快速序贯苯巴比妥治疗
Pediatrics. 1989 May;83(5):674-8.
10
Developmental aspects of phenobarbital dosage requirements in newborn infants with seizures.新生儿癫痫患者苯巴比妥剂量需求的发育方面
J Perinatol. 1988 Fall;8(4):318-20.

引用本文的文献

1
Pharmacokinetic variability of phenobarbital: a systematic review of population pharmacokinetic analysis.苯巴比妥的药代动力学变异性:系统评价群体药代动力学分析。
Eur J Clin Pharmacol. 2021 Mar;77(3):291-309. doi: 10.1007/s00228-020-03011-x. Epub 2020 Oct 19.
2
Pharmacokinetic considerations in the treatment of childhood epilepsy.
Paediatr Drugs. 2003;5(4):267-77. doi: 10.2165/00128072-200305040-00005.
3
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.抗癫痫药物在儿科患者中的临床药代动力学。第一部分:苯巴比妥、扑米酮、丙戊酸、乙琥胺和甲琥胺。
Clin Pharmacokinet. 1995 Oct;29(4):257-86. doi: 10.2165/00003088-199529040-00005.
4
Therapeutic drug monitoring in the neonate and paediatric age group. Problems and clinical pharmacokinetic implications.新生儿及儿童年龄组的治疗药物监测。问题及临床药代动力学影响。
Clin Pharmacokinet. 1990 Jul;19(1):1-10. doi: 10.2165/00003088-199019010-00001.
5
Pharmacokinetic and pharmacodynamic data collection in children and neonates. A quiet frontier.
Clin Pharmacokinet. 1992 Jul;23(1):1-9. doi: 10.2165/00003088-199223010-00001.